Glycogen Storage Disease Type I

Glycogen Storage Disease Type I, also known as Gierke's Disease, is a specific type of glycogen storage disease. It happens when the body doesn't make enough glucose-6-phosphatase. This causes sugar to build up in the liver and kidneys, making them very large. It also leads to low blood sugar, high lactic acid, and high levels of fats in the blood. It often shows up in early childhood.

Condition

What people with Glycogen Storage Disease Type I report

Every report comes from a Lived member, sent anonymously.

Have you tried Jardiance (Empagliflozin) for Glycogen Storage Disease Type I?

NameHow it went

About Glycogen Storage Disease Type I

What It Is

Glycogen storage disease type I (GSD I), also called von Gierke disease, is a rare inherited condition in which the liver cannot release glucose into the blood when a person goes without food. Normally the liver keeps blood sugar steady between meals and overnight, both by breaking down its stored sugar (glycogen) and by making new glucose. In GSD I the last step of both processes is blocked, so blood sugar can fall within a few hours of eating, and the unused material is turned into glycogen and fat that build up in the liver and kidneys. Symptoms usually appear around 3 to 4 months of age, when babies begin going longer between feeds. Low blood sugar (hypoglycemia) can cause irritability, sweating, unusual sleepiness or seizures. The same backlog raises levels of lactic acid, blood fats (triglycerides and cholesterol) and uric acid. Children often have a greatly enlarged liver with a prominent belly, full round cheeks, thin arms and legs, and short stature. Some severely affected newborns have low blood sugar within days of birth, while a few people with milder forms are not diagnosed until adulthood. There are two main types. GSD Ia, about 80% of cases, involves the enzyme glucose-6-phosphatase itself. GSD Ib involves the transporter that carries sugar to that enzyme, and it also weakens neutrophils, the white blood cells that fight bacteria. People with type Ib therefore also tend to have frequent infections, mouth sores and gum disease, and inflammatory bowel disease.

Causes & Risk Factors

GSD I is caused by changes (variants) in one of two genes: G6PC1 for type Ia and SLC37A4 for type Ib. It is inherited in an autosomal recessive pattern, meaning a person has the condition only when they inherit a non-working copy of the gene from each parent. Parents who each carry one copy are healthy. When both parents are carriers, each pregnancy has a 25% chance of a child with GSD I, a 50% chance of a child who is a healthy carrier, and a 25% chance of neither. Overall, GSD I affects about 1 in 100,000 people. The condition is present from birth and nothing a parent did caused it. What varies day to day are the situations that bring on low blood sugar: going longer than usual without food, a missed overnight feed or cornstarch dose, more physical activity than planned, and illnesses such as stomach bugs that interrupt eating. Getting too much cornstarch or sugar also causes problems, adding to liver size and blood fats, so the aim is the right amount rather than as much as possible.

How It's Diagnosed

GSD I is usually suspected in a baby or young child who has low blood sugar after short gaps between feeds and an enlarged liver. Blood tests typically show low glucose together with high lactic acid, triglycerides, cholesterol and uric acid. Other glycogen storage diseases (types III, VI and IX) and some other conditions can look similar, so testing is aimed at telling them apart. Genetic testing confirms the diagnosis by finding two disease-causing variants in G6PC1 or SLC37A4, and it shows whether the type is Ia or Ib. If the genetic result is unclear, a liver biopsy can measure enzyme activity, although this only confirms type Ia. A complete blood count checks neutrophil levels, which matters for type Ib. Once a family's variants are known, brothers and sisters can be tested soon after birth so treatment starts early, and carrier testing and testing during pregnancy are available.

Treatment Options

There is no cure that removes the need for careful eating, but treatment works well: it keeps blood sugar steady, calms the related chemical imbalances and allows normal growth. The foundation is a medically prescribed diet planned with a metabolic specialist and a metabolic dietitian. Young babies typically feed about every 2 hours, using a formula free of sucrose, fructose and lactose, and many children receive continuous overnight feeding through a tube so they do not have to be woken. Between about 6 and 12 months, uncooked cornstarch becomes the main tool, because it is digested slowly and releases glucose over several hours. Doses are usually repeated every 3 to 5 hours, day and night, alongside regular meals high in complex carbohydrates. Sugars the liver cannot turn into glucose (table sugar, fructose, galactose from milk, honey, syrups and sorbitol) are limited, and vitamin and mineral supplements fill the gaps the diet leaves. The amount is adjusted over time: too little causes low blood sugar, while too much leads to weight gain, higher blood fats and a larger liver. Other medicines treat specific complications. These include allopurinol to lower uric acid and prevent gout, ACE inhibitors (blood pressure medicines that also protect the kidneys) when protein appears in the urine, citrate to help prevent kidney stones, and cholesterol-lowering drugs when needed. People with GSD Ib also need treatment for their neutrophils. Injections of G-CSF (granulocyte colony-stimulating factor), such as filgrastim (Neupogen), boost neutrophil production and reduce infections, though long-term use has raised concern about blood cancers. Empagliflozin (Jardiance), a diabetes pill, is now widely used off-label in type Ib because it clears a toxic sugar byproduct that damages neutrophils. The studies so far are not randomized, but they show better neutrophil counts, fewer infections and less bowel inflammation, often allowing G-CSF to be reduced or stopped. In 2026 the FDA granted accelerated approval to the first gene therapy for GSD Ia, pariglasgene brecaparvovec (Genglycos), for people aged 8 and older. A single infusion delivers a working copy of the G6PC1 gene to the liver. In its main trial it reduced daily cornstarch needs by about 41%, compared with about 10% on placebo. It does not replace the diet, low glucose readings became slightly more frequent in the trial, its long-term benefit is still being confirmed, and a course of steroids is needed afterward to limit liver inflammation. People with antibodies to the virus that carries the gene, or with severe liver scarring, cannot receive it. Liver transplantation restores the liver's ability to make glucose, but as a major operation with long-term trade-offs it is reserved for people whose disease cannot be controlled with medical treatment. Kidney transplantation may be needed if kidney failure develops.

What to Expect

GSD I is lifelong, but with steady treatment most children grow normally, go through puberty and live into adulthood. The daily routine is demanding. Cornstarch or feeds have to be timed around the clock, carried everywhere and adjusted for exercise, illness, growth and pregnancy, and many families describe broken sleep and constant worry about missed doses. That concern is real: missing a single overnight dose, or a feeding pump stopping, can lead to severe low blood sugar with seizures and can be fatal. Alarms, backup supplies and regular glucose checks, by finger-stick or a continuous glucose monitor (a small sensor worn on the skin), help keep the routine safe. Because the brain can run on lactic acid for a while, some people feel no warning symptoms until blood sugar is very low, which is why scheduled checks matter more than waiting for symptoms. Regular follow-up with a metabolic clinic includes blood tests every 6 to 12 months for glucose, lactate, blood fats, uric acid and liver and kidney function. Liver adenomas, noncancerous growths, often appear in the teens or twenties, and a small share can become cancer, so the liver is imaged on a schedule: ultrasound every year or two in childhood, then ultrasound, CT or MRI every 6 to 12 months from about age 16, or sooner once adenomas are found. Yearly kidney ultrasounds start around age 10, along with urine tests for protein, blood pressure checks and bone density scans. Some complications develop even with good control, but keeping blood sugar and lab values in range over the years is linked to fewer of them. People with GSD Ib also live with a higher risk of infections, mouth and gum problems and bowel inflammation, and need regular blood counts. Many women with GSD I have had successful pregnancies, but pregnancy needs planning with the metabolic team, because cornstarch needs change and existing adenomas can grow. Alcohol is best limited, since it adds strain to the liver.

When to Seek Help

Have a baby or child evaluated if they have episodes of low blood sugar, an enlarged liver or swollen belly, or poor growth, especially if symptoms appear when feeds are spaced further apart. For someone already diagnosed, contact the metabolic team promptly when low readings become more frequent, during any illness that reduces eating, or when feeds or cornstarch are becoming hard to take. In type Ib, a fever or new mouth sores also call for a prompt call to the care team because of the infection risk. Go to the emergency department straight away if vomiting, diarrhea or illness means feeds or cornstarch cannot be kept down, or if low blood sugar does not recover with the usual treatment. The treatment is glucose given through a vein (IV), and it should start quickly. Bring the emergency letter or protocol from the metabolic team, because glucagon, the usual rescue injection for low blood sugar, does not work in GSD I, and IV fluids containing lactate (lactated Ringer's) should be avoided. Call 911 for a seizure or if the person is unresponsive or cannot be woken.

Questions to Ask Your Doctor

  1. 1.Is this type Ia or Ib, and how does that change the treatment plan?
  2. 2.How should cornstarch and overnight feeds be timed at this age, and how will we know whether the dose is too low or too high?
  3. 3.What is our sick-day plan, and can you give us an emergency letter to take to the hospital?
  4. 4.Which tests and scans will watch the liver, kidneys and bones, and how often?
  5. 5.Is gene therapy, or for type Ib empagliflozin, a reasonable option for us, and what are the trade-offs?

Last reviewed • Oct 2026

Educational content, not medical advice.